Australian Clinical Labs Limited
ASX:ACL.AX
3.5 (AUD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 689.728 | 692.103 | 989.298 | 641.311 | 487.53 | 445.89 | 376.088 | 339.768 |
| Cost of Revenue
| 442.368 | 126.083 | 207.592 | 119.585 | 402.489 | 313.893 | 265.846 | 57.679 |
| Gross Profit
| 247.36 | 566.02 | 781.706 | 521.726 | 85.041 | 131.997 | 110.242 | 282.089 |
| Gross Profit Ratio
| 0.359 | 0.818 | 0.79 | 0.814 | 0.174 | 0.296 | 0.293 | 0.83 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 312.668 | 297.394 | 314.003 | 249.685 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -225.475 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 87.193 | 297.394 | 314.003 | 249.685 | 69.509 | 139.575 | 116.151 | 251.501 |
| Other Expenses
| 201.828 | 10.026 | -1.073 | 3.357 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 81.547 | 514.053 | 514.029 | 416.536 | 69.509 | 139.575 | 116.151 | 306.323 |
| Operating Income
| 56.905 | 51.85 | 256.239 | 97.592 | 15.532 | -7.578 | -5.909 | -20.569 |
| Operating Income Ratio
| 0.083 | 0.075 | 0.259 | 0.152 | 0.032 | -0.017 | -0.016 | -0.061 |
| Total Other Income Expenses Net
| -20.539 | -3.657 | -12.777 | -35.957 | 1.168 | 2.378 | -1.732 | -58.2 |
| Income Before Tax
| 36.366 | 48.31 | 254.9 | 86.653 | 30.891 | -9.704 | -7.641 | -27.612 |
| Income Before Tax Ratio
| 0.053 | 0.07 | 0.258 | 0.135 | 0.063 | -0.022 | -0.02 | -0.081 |
| Income Tax Expense
| 12.122 | 12.268 | 76.498 | 26.264 | -10.425 | 0.82 | 1.371 | 3.581 |
| Net Income
| 23.934 | 35.901 | 178.244 | 60.373 | 41.255 | -10.524 | -9.012 | -24.031 |
| Net Income Ratio
| 0.035 | 0.052 | 0.18 | 0.094 | 0.085 | -0.024 | -0.024 | -0.071 |
| EPS
| 0.12 | 0.18 | 0.89 | 0.4 | 0.2 | -0.052 | -0.045 | -0.119 |
| EPS Diluted
| 0.12 | 0.18 | 0.88 | 0.4 | 0.2 | -0.052 | -0.045 | -0.119 |
| EBITDA
| 181.833 | 184.93 | 372.745 | 196.674 | 116.3 | 3.928 | 5.409 | -8.059 |
| EBITDA Ratio
| 0.264 | 0.252 | 0.366 | 0.289 | 0.192 | 0.009 | 0.014 | -0.024 |